ArticleActa neuropathologica communications2024
Letter to the editor on: prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
Cinzia Bocca, Judith Kouassi-Nzoughet, Juan Manuel Chao de la Barca, Dominique Bonneau, Christophe Verny, Philippe Gohier, Christophe Orssaud, Pascal Reynier
Open access · goldAbstract readLetterComment
In one paragraphArticle in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors at 3 institutions in 1 country.
Cinzia Bocca *Laboratoire de Biochimie et biologie moléculaire, Centre Hospitalier Universitaire (CHU), Angers, France.
Judith Kouassi-Nzoughet *Faculté de Pharmacie de Paris, Université Paris Cité, CNRS, CiTCoM, Paris, F-75006, France.
Juan Manuel Chao de la BarcaLaboratoire de Biochimie et biologie moléculaire, Centre Hospitalier Universitaire (CHU), Angers, France.
Dominique BonneauUnité Mixte de Recherche (UMR) MITOVASC, Institut National de la Santé et de la Recherche Médicale (INSERM U1083), Centre National de la Recherche Scientifique (CNRS 6015), Université d'Angers, Angers, France.
Christophe VernyUnité Mixte de Recherche (UMR) MITOVASC, Institut National de la Santé et de la Recherche Médicale (INSERM U1083), Centre National de la Recherche Scientifique (CNRS 6015), Université d'Angers, Angers, France.
Philippe GohierDépartement d'Ophtalmologie, Centre Hospitalier Universitaire (CHU), Angers, France.
Christophe OrssaudFunctional Unit of Ophthalmology, Ophtara Rare disease Center, Sensgène Filière, European Hospital Georges Pompidou, ERN EYE, University Hospital Paris Centre, Assistance Publique des Hôpitaux de Paris, Paris, France.
Pascal ReynierLaboratoire de Biochimie et biologie moléculaire, Centre Hospitalier Universitaire (CHU), Angers, France. pareynier@chu-angers.fr.ORCID 0000-0003-0802-4608 Centre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire d'Angers · FRHôpital Européen Georges-Pompidou · FR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
NiacinamideRotenoneDNA, MitochondrialMitochondriaRetinal Ganglion CellsDNA, MitochondrialNiacinamideRotenoneGlaucomaLeber hereditary optic neuropathyMitochondriaNicotinamideOptic neuropathyRetinal ganglion cellsVitamine B3
Identifiers
PMID38581047
PMCPMC10996267
OpenAlexW4393990394
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390